Vitamin D supplementation has no effect on insulin sensitivity or secretion in Vitamin D-deficient, overweight or obese adults: A randomized placebo-controlled trial

American Journal of Clinical Nutrition

Volumn 105, Issue 6, 2017, Pages 1372-1381

  Mousa, Aya ^a   Naderpoor, Negar ^a,b   De Courten, Maximilian P J ^c   Teede, Helena ^a,b   Kellow, Nicole ^a   Walker, Karen ^a   Scragg, Robert ^d   De Courten, Barbora ^a  

^a MONASH UNIVERSITY   (Australia)

^b SOUTHERN HEALTH   (Australia)

^c VICTORIA UNIVERSITY   (Australia)

^d UNIVERSITY OF AUCKLAND   (New Zealand)

Author keywords

Insulin secretion; Insulin sensitivity; Obesity; Randomized trial; RCT; Vitamin D

Indexed keywords

25 HYDROXYVITAMIN D; COLECALCIFEROL; GLUCOSE; INSULIN; LIPID; PLACEBO; 25-HYDROXYVITAMIN D; GLUCOSE BLOOD LEVEL; VITAMIN D;

ADULT; ADULT DISEASE; ARTICLE; BODY COMPOSITION; BODY MASS; BOLUS INJECTION; CARDIOVASCULAR RISK; CLINICAL ARTICLE; CONTROLLED STUDY; DIETARY INTAKE; DOUBLE BLIND PROCEDURE; DRUG WITHDRAWAL; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT FREE MASS; FAT MASS; FEMALE; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; GOLD STANDARD; GROUPS BY AGE; HUMAN; HYPERINSULINEMIC-EUGLYCEMIC CLAMP TECHNIQUE; INSULIN BLOOD LEVEL; INSULIN RELEASE; INSULIN RESISTANCE; INSULIN SENSITIVITY; INTRAVENOUS GLUCOSE TOLERANCE TEST; LIPID BLOOD LEVEL; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PARALLEL DESIGN; PHYSICAL ACTIVITY; RANDOMIZED CONTROLLED TRIAL; SEX DIFFERENCE; SUN EXPOSURE; THROMBOPHLEBITIS; TREATMENT DURATION; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN INTAKE; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; BLOOD; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENT; GLUCOSE TOLERANCE TEST; METABOLISM; PHOTON ABSORPTIOMETRY; SECRETION (PROCESS);

ABSORPTIOMETRY, PHOTON; ADULT; BLOOD GLUCOSE; BODY COMPOSITION; CHOLECALCIFEROL; DIABETES MELLITUS, TYPE 2; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FEMALE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; INSULIN RESISTANCE; MALE; OBESITY; OVERWEIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 85020535748     PISSN: 00029165     EISSN: 19383207     Source Type: Journal    
DOI: 10.3945/ajcn.117.152736     Document Type: Article

References (45)

1. Mason C, Xiao L, Imayama I, Duggan C, Wang CY, Korde L, McTiernan A. Vitamin D3 supplementation during weight loss: a doubleblind randomized controlled trial. Am J Clin Nutr 2014;99:1015-25.
2. Pittas AG, Lau J, Hu FB, Dawson-Hughes B. The role of Vitamin D and calcium in type 2 diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2007;92:2017-29.
3. Holick MF. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009;19:73-8.
4. Holick MF. Vitamin D deficiency in 2010: health benefits of Vitamin D and sunlight: a D-bate. Nat Rev Endocrinol 2011;7:73-5.
5. Australian Government, Department of Health and Aging, Council. NHaMR. Nutrient reference values for Australia and New Zealand. Executive summary. Canberra (Australia): NHMRC; 2006.
6. Ilahi M, Armas LA, Heaney RP. Pharmacokinetics of a single, large dose of cholecalciferol. Am J Clin Nutr 2008;87:688-91.
7. Vieth R, Chan PC, MacFarlane GD. Efficacy and safety of Vitamin D3 intake exceeding the lowest observed adverse effect level. Am J Clin Nutr 2001;73:288-94.
8. Mai XM, Chen Y, Camargo CA Jr., Langhammer A. Cross-sectional and prospective cohort study of serum 25-hydroxyVitamin D level and obesity in adults: the HUNT study. Am J Epidemiol 2012;175:1029-36.
9. Need AG, O'Loughlin PD, Horowitz M, Nordin BE. Relationship between fasting serum glucose, age, body mass index and serum 25 hydroxyVitamin D in postmenopausal women. Clin Endocrinol (Oxf) 2005;62:738-41.
10. Liu E, Meigs JB, Pittas AG, McKeown NM, Economos CD, Booth SL, Jacques PF. Plasma 25-hydroxyVitamin d is associated with markers of the insulin resistant phenotype in nondiabetic adults. J Nutr 2009;139: 329-34.
11. Chiu KC, Chu A, Go VL, Saad MF. HypoVitaminosis D is associated with insulin resistance and beta cell dysfunction. Am J Clin Nutr 2004; 79:820-5.
12. Pinelli NR, Jaber LA, Brown MB, Herman WH. Serum 25-hydroxy Vitamin d and insulin resistance, metabolic syndrome, and glucose intolerance among Arab Americans. Diabetes Care 2010;33:1373-5.
13. Khan H, Kunutsor S, Franco OH, Chowdhury R. Vitamin D, type 2 diabetes and other metabolic outcomes: a systematic review and metaanalysis of prospective studies. Proc Nutr Soc 2013;72:89-97.
14. Pittas AG, Chung M, Trikalinos T, Mitri J, Brendel M, Patel K, Lichtenstein AH, Lau J, Balk EM. Systematic review: Vitamin D and cardiometabolic outcomes. Ann Intern Med 2010;152:307-14.
15. Seida JC, Mitri J, Colmers IN, Majumdar SR, Davidson MB, Edwards AL, Hanley DA, Pittas AG, Tjosvold L, Johnson JA. Clinical review: effect of Vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis. J Clin Endocrinol Metab 2014;99:3551-60.
16. Meyer HE, Holvik K, Lips P. Should Vitamin D supplements be recommended to prevent chronic diseases? BMJ 2015;350:h321.
17. de Courten B, Mousa A, Naderpoor N, Teede H, de Courten MPJ, Scragg R. Vitamin D supplementation for the prevention of type 2 diabetes in overweight adults: study protocol for a randomized controlled trial. Trials 2015;16:335.
18. Shoelson SE, Herrero L, Naaz A. Obesity, inflammation and insulin resistance. Gastroenterology 2007;132:2169-80.
19. Hathcock JN, Shao A, Vieth R, Heaney R. Risk assessment for Vitamin D. Am J Clin Nutr 2007;85:6-18.
20. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-53.
21. Sourris KC, Lyons JG, de Courten MP, Dougherty SL, Henstridge DC, Cooper ME, Hage M, Dart A, Kingwell BA, Forbes JM, et al. c-Jun NH2-terminal kinase activity in subcutaneous adipose tissue but not nuclear factor-kappaB activity in peripheral blood mononuclear cells is an independent determinant of insulin resistance in healthy individuals. Diabetes 2009;58:1259-65.
22. Craig CL, Marshall AL, Sjostrom M, Bauman AE, Booth ML, Ainsworth BE, Pratt M, Ekelund U, Yngve A, Sallis JF, et al. International physical activity questionnaire: 12-country reliability and validity. Med Sci Sports Exerc 2003;35:1381-95.
23. Borissova AM, Tankova T, Kirilov G, Dakovska L, Kovacheva R. The effect of Vitamin D3 on insulin secretion and peripheral insulin sensitivity in type 2 diabetic patients. Int J Clin Pract 2003;57:258-61.
24. Bergman RN, Finegood DT, Ader M. Assessment of insulin sensitivity in vivo. Endocr Rev 1985;6:45-86.
25. Simha V, Mahmood M, Ansari M, Spellman CW, Shah P. Effect of Vitamin D replacement on insulin sensitivity in subjects with Vitamin D deficiency. J Investig Med 2012;60:1214-8.
26. Fliser D, Stefanski A, Franek E, Fode P, Gudarzi A, Ritz E. No effect of calcitriol on insulin-mediated glucose uptake in healthy subjects. Eur J Clin Invest 1997;27:629-33.
27. Grimnes G, Figenschau Y, Almas B, Jorde R. Vitamin D, insulin secretion, sensitivity, and lipids: results from a case-control study and a randomized controlled trial using hyperglycemic clamp technique. Diabetes 2011;60:2748-57.
28. Nagpal J, Pande JN, Bhartia A. A double-blind, randomized, placebocontrolled trial of the short-term effect of Vitamin D3 supplementation on insulin sensitivity in apparently healthy, middle-aged, centrally obese men. Diabet Med 2009;26:19-27.
29. Pittas AG, Harris SS, Stark PC, Dawson-Hughes B. The effects of calcium and Vitamin D supplementation on blood glucose and markers of inflammation in nondiabetic adults. Diabetes Care 2007; 30:980-6.
30. Wamberg L, Kampmann U, Stodkilde-Jorgensen H, Rejnmark L, Pedersen SB, Richelsen B. Effects of Vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low Vitamin D levels -results from a randomized trial. Eur J Intern Med 2013;24:644-9.
31. Beilfuss J, Berg V, Sneve M, Jorde R, Kamycheva E. Effects of a 1-year supplementation with cholecalciferol on interleukin-6, tumor necrosis factor-alpha and insulin resistance in overweight and obese subjects. Cytokine 2012;60:870-4.
32. Bock G, Prietl B, Mader JK, Holler E, Wolf M, Pilz S, Graninger WB, Obermayer-Pietsch BM, Pieber TR. The effect of Vitamin D supplementation on peripheral regulatory T cells and beta cell function in healthy humans: a randomized controlled trial. Diabetes Metab Res Rev 2011;27:942-5.
33. Carrillo AE, Flynn MG, Pinkston C, Markofski MM, Jiang Y, Donkin SS, Teegarden D. Impact of Vitamin D supplementation during a resistance training intervention on body composition, muscle function, and glucose tolerance in overweight and obese adults. Clin Nutr 2013;32:375-81.
34. Jorde R, Sneve M, Torjesen P, Figenschau Y. No improvement in cardiovascular risk factors in overweight and obese subjects after supplementation with Vitamin D3 for 1 year. J Intern Med 2010;267:462-72.
35. Major GC, Alarie F, Dore J, Phouttama S, Tremblay A. Supplementation with calcium + Vitamin D enhances the beneficial effect of weight loss on plasma lipid and lipoprotein concentrations. Am J Clin Nutr 2007;85:54-9.
36. Muldowney S, Lucey AJ, Hill TR, Seamans KM, Taylor N, Wallace JM, Horigan G, Barnes MS, Bonham MP, Duffy EM, et al. Incremental cholecalciferol supplementation up to 15 mg/d throughout winter at 51-558 N has no effect on biomarkers of cardiovascular risk in healthy young and older adults. J Nutr 2012;142:1519-25.
37. Wood AD, Secombes KR, Thies F, Aucott L, Black AJ, Mavroeidi A, Simpson WG, Fraser WD, Reid DM, Macdonald HM. Vitamin D3 supplementation has no effect on conventional cardiovascular risk factors: a parallel-group, double-blind, placebo-controlled RCT. J Clin Endocrinol Metab 2012;97:3557-68.
38. Zittermann A, Frisch S, Berthold HK, Gotting C, Kuhn J, Kleesiek K, Stehle P, Koertke H, Koerfer R. Vitamin D supplementation enhances the beneficial effects of weight loss on cardiovascular disease risk markers. Am J Clin Nutr 2009;89:1321-7.
39. Salehpour A, Shidfar F, Hosseinpanah F, Vafa M, Razaghi M, Amiri F. Does Vitamin D3 supplementation improve glucose homeostasis in overweight or obese women? A double-blind, randomized, placebocontrolled clinical trial. Diabet Med 2013;30:1477-81.
40. Wang L, Manson JE, Sesso HD. Calcium intake and risk of cardiovascular disease: a review of prospective studies and randomized clinical trials. Am J Cardiovasc Drugs 2012;12:105-16.
41. von Hurst PR, Stonehouse W, Coad J. Vitamin D supplementation reduces insulin resistance in South Asian women living in New Zealand who are insulin resistant and Vitamin D deficient -a randomised, placebo-controlled trial. Br J Nutr 2010;103:549-55.
42. Poolsup N, Suksomboon N, Plordplong N. Effect of Vitamin D supplementation on insulin resistance and glycaemic control in prediabetes: a systematic review and meta-analysis. Diabet Med 2016;33: 290-9.
43. Manousopoulou A, Al-Daghri NM, Garbis SD, Chrousos GP. Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis. Eur J Clin Invest 2015;45:1113-26.
44. Beveridge LA, Struthers AD, Khan F, Jorde R, Scragg R, Macdonald HM, Alvarez JA, Boxer RS, Dalbeni A, Gepner AD, et al. Effect of Vitamin D supplementation on blood pressure: a systematic review and metaanalysis incorporating individual patient data. JAMA Intern Med 2015; 175:745-54.
45. Jorde R, Grimnes G. Vitamin D and metabolic health with special reference to the effect of Vitamin D on serum lipids. Prog Lipid Res 2011;50:303-12.